To evaluate efficacy and safety of dual therapy with Daclatasvir and Asunaprevir in older patients with chronic hepatitis C
Latest Information Update: 29 Sep 2017
At a glance
- Drugs Asunaprevir (Primary) ; Daclatasvir (Primary)
- Indications Hepatitis C
- Focus Adverse reactions; Therapeutic Use
- 29 Sep 2017 New trial record